BioNexus Gene Lab Income from Continuous Operations 2019-2025 | BGLC
BioNexus Gene Lab income from continuous operations from 2019 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| BioNexus Gene Lab Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-2 |
| 2023 | $-3 |
| 2022 | $0 |
| 2021 | $1 |
| 2020 | $1 |
| 2019 | $0 |
| 2018 | $0 |
| BioNexus Gene Lab Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-1 |
| 2024-12-31 | $0 |
| 2024-09-30 | $-1 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $-3 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $1 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.009B | $0.010B |
| BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.134B | 27.29 |
| CVS Health (CVS) | United States | $76.787B | 9.54 |
| Elevance Health (ELV) | United States | $65.099B | 8.76 |
| Cencora (COR) | United States | $56.278B | 19.58 |
| DiDi Global (DIDIY) | China | $25.745B | 27.35 |
| Labcorp Holdings (LH) | United States | $22.177B | 17.50 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $17.681B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.851B | 0.00 |
| ICON (ICLR) | Ireland | $15.102B | 14.53 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Solventum (SOLV) | United States | $12.933B | 13.69 |
| Medpace Holdings (MEDP) | United States | $12.571B | 33.27 |
| Revvity (RVTY) | United States | $12.220B | 21.03 |
| Viatris (VTRS) | United States | $11.044B | 3.79 |
| Avantor (AVTR) | United States | $9.683B | 14.07 |
| Sonic Healthcare (SKHHY) | Australia | $9.143B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.690B | 17.03 |
| HealthEquity (HQY) | United States | $8.305B | 36.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.515B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.066B | 29.83 |
| BrightSpring Health Services (BTSG) | United States | $3.609B | 33.11 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Surgery Partners (SGRY) | United States | $2.725B | 35.43 |
| Organon (OGN) | United States | $2.654B | 2.82 |
| Concentras Parent (CON) | United States | $2.520B | 14.56 |
| Alignment Healthcare (ALHC) | United States | $2.327B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.278B | 87.73 |
| Progyny (PGNY) | United States | $1.981B | 43.60 |
| GoodRx Holdings (GDRX) | United States | $1.786B | 35.71 |
| PACS (PACS) | United States | $1.782B | 0.00 |
| Premier (PINC) | United States | $1.744B | 13.23 |
| Ardent Health (ARDT) | United States | $1.582B | 6.74 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.853B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.758B | 7.10 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.686B | 4.62 |
| Nutex Health (NUTX) | United States | $0.528B | 7.99 |
| InnovAge Holding (INNV) | United States | $0.518B | 0.00 |
| Omada Health (OMDA) | $0.495B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.493B | 0.00 |
| LifeMD (LFMD) | United States | $0.486B | 0.00 |
| So-Young (SY) | China | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.328B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.284B | 0.00 |
| Beauty Health (SKIN) | United States | $0.226B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.192B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Biodesix (BDSX) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |